Teladoc Health, Inc. (TDOC) - Q1 2026 10-Q Summary
Business Context and Reporting Period
This filing covers the quarterly period ended March 31, 2026. Teladoc Health operates as a global leader in virtual care through two primary segments: Integrated Care (virtual medical services, chronic care management) and BetterHelp (virtual therapy and wellness). The company reported a net loss for the quarter but demonstrated improved operational efficiency compared to the prior year.
Key Financial Metrics
| Metric | Q1 2026 | Q1 2025 |
|---|---|---|
| Revenue | $613.8 million | $629.4 million |
| Net Loss | $(63.8) million | $(93.0) million |
| Loss Per Share (Diluted) | $(0.36) | $(0.53) |
| Adjusted EBITDA | $58.2 million | $58.1 million |
| Operating Cash Flow | $9.5 million | $15.9 million |
| Free Cash Flow | $(26.3) million | $(15.7) million |
| Cash and Equivalents | $750.7 million | $1,193.3 million |
| Convertible Senior Notes (Net) | $995.8 million | $994.9 million |
Material Changes vs. Prior Period
- Revenue Decline: Total revenue decreased 2% year-over-year, driven by a 9% drop in BetterHelp revenue due to a 9% decrease in paying users. This was partially offset by a 2% increase in Integrated Care revenue.
- Improved Profitability: Net loss narrowed by 31% to $63.8 million, primarily due to the absence of a $59.1 million goodwill impairment charge recorded in Q1 2025 related to the Catapult Health acquisition.
- Expense Reductions: Advertising and marketing expenses fell 10% to $151.5 million. General and administrative expenses decreased 9% to $102.1 million.
- Restructuring Costs: Restructuring charges increased to $12.0 million (up from $4.3 million), driven by employee severance and office space reductions.
- Amortization Increase: Amortization of intangible assets rose 7% to $89.8 million, partly due to a strategic brand transition accelerating the amortization of trademark assets.
Guidance, Outlook, and Risks
- Restructuring Outlook: Management expects total pre-tax restructuring costs for the full year 2026 to remain in the range of $15.0 million to $20.0 million.
- Goodwill Risk: The company's market capitalization remains below its book value. While no impairment was recorded in Q1 2026, management continues to monitor the BetterHelp reporting unit for potential future impairment.
- Debt Obligations: The company holds $1.0 billion in 1.25% convertible senior notes due in June 2027. A $300 million revolving credit facility was established in July 2025, with approximately $296.6 million available as of March 31, 2026.
- Legal Contingencies: The company faces multiple securities class actions and derivative lawsuits regarding alleged misstatements and BetterHelp data privacy issues. Management asserts substantial defenses and does not currently expect a material adverse impact.
- Macro Risks: Potential tariffs on imported components for medical devices and global trade policy changes pose uncertainty to future operations.
Investor Verification Checklist
- Goodwill Impairment Status: Verify if the sustained low market cap triggers a future impairment test for the $283.2 million BetterHelp goodwill balance.
- BetterHelp User Trends: Monitor the 9% decline in paying users and the effectiveness of reduced marketing spend in stabilizing the segment.
- Debt Conversion Risk: Assess the impact of the $1.0 billion convertible notes maturing in June 2027 and the company's ability to refinance or convert them.
- Restructuring Execution: Track the remaining $3.0 million to $8.0 million of expected restructuring costs for 2026 and their impact on cash flow.
- Legal Proceedings: Review updates on the consolidated securities litigation and BetterHelp class actions for potential settlement costs or judgments.